Model DetailsPancreas adenocarcinoma - ductal
Model Name |
Pancreas adenocarcinoma - ductal | Strain |
C57BL/6-Krastm4Tyj/+ Tg(Pdx1-cre)6Tuv Trp53tm2Tyj/+ |
Tumor Inducing Agent(s) |
Antibody, Chemical/Drug : gemcitabine • anti-PD1 antibody • CCR2 inhibitor (CCX598) • anti-CTLA4 antibody |
Tumor Synonyms |
Pancreatic ductal adenocarcinoma (PDA) • Pancreatic ductal adenocarcinoma (PDA) kidney metastasis • Pancreatic ductal adenocarcinoma (PDA) stomach metastasis • Pancreatic ductal adenocarcinoma (PDA) gallbladder metastasis • Pancreatic ductal adenocarcinoma (PDA) liver metastasis • Pancreatic ductal adenocarcinoma (PDA) spleen metastasis • Pancreatic ductal adenocarcinoma (PDA) diaphragm metastasis • Pancreatic ductal adenocarcinoma (PDA) lymph node metastasis • Pancreatic ductal adenocarcinoma (PDA) metastases |
Strain Synonym |
KPC |
| Organ Affected | Sex | Frequency | Age Of Detection | Additional Information Expand all Collapse all | Reference |
|---|---|---|---|---|---|
| Pancreas | Unspecified |
100% (12 of 12 mice) |
|
Dixit A, JCI Insight 2022 Nov 22;7(22): | |
| Gallbladder | Unspecified |
17% (2 of 12 mice) |
|
Dixit A, JCI Insight 2022 Nov 22;7(22): | |
| Kidney | Unspecified |
0% (0 of 12 mice) |
|
Dixit A, JCI Insight 2022 Nov 22;7(22): | |
| Liver | Unspecified |
41.67% (5 of 12 mice) |
|
Dixit A, JCI Insight 2022 Nov 22;7(22): | |
| Lymph node | Unspecified |
75% (9 of 12 mice) |
|
Dixit A, JCI Insight 2022 Nov 22;7(22): | |
| Muscle - Striated - Skeletal - Diaphragm | Unspecified |
33% (4 of 12 mice) |
|
Dixit A, JCI Insight 2022 Nov 22;7(22): | |
| Spleen | Unspecified |
0% (0 of 12 mice) |
|
Dixit A, JCI Insight 2022 Nov 22;7(22): | |
| Stomach | Unspecified |
17% (2 of 12 mice) |
|
Dixit A, JCI Insight 2022 Nov 22;7(22): | |
| (Unspecified organ) | Unspecified |
100% (12 of 12 mice) |
|
Dixit A, JCI Insight 2022 Nov 22;7(22): |